Scarica l'app Stockscreener
1.23
2.38%
-0.03
Dopo l'orario di chiusura:
1.25
0.02
+1.63%
Precedente Chiudi:
$1.26
Aprire:
$1.25
Volume 24 ore:
798.38K
Relative Volume:
0.67
Capitalizzazione di mercato:
$168.79M
Reddito:
$4.35M
Utile/perdita netta:
$-45.53M
Rapporto P/E:
-1.1389
EPS:
-1.08
Flusso di cassa netto:
$-44.79M
1 W Prestazione:
+0.00%
1M Prestazione:
+14.95%
6M Prestazione:
+12.84%
1 anno Prestazione:
+51.85%
Intervallo 1D:
$1.19
$1.27
Intervallo di 1 settimana:
$1.14
$1.27
Portata 52W:
$0.7501
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Nome
Lucid Diagnostics Inc
Settore
Industria
Telefono
212 949 4319
Indirizzo
360 MADISON AVENUE, NEW YORK
Confronta LUCD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.23 | 121.25M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
127.63 | 231.95B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
97.78 | 142.60B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.25 | 141.45B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.04 | 123.83B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.65 | 43.07B | 5.69B | 1.41B | 577.90M | 6.9828 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-12-27 | Iniziato | Ascendiant Capital Markets | Buy |
| 2021-11-08 | Iniziato | BTIG Research | Buy |
| 2021-11-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-11-08 | Iniziato | Needham | Buy |
Lucid Diagnostics Inc Borsa (LUCD) Ultime notizie
Can Lucid Diagnostics Inc. stock sustain revenue growth2025 Trading Volume Trends & Accurate Entry/Exit Alerts - newser.com
What Makes Lucid Diagnostics Inc. (LUCD) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit - GuruFocus
22-23: Lucid Diagnostics’ CFO Dennis McGrath to hold one-on-one investor meetings at Maxim Growth Summit in NYC - Stock Titan
Is Lucid Diagnostics Inc. stock oversold or undervalued2025 Price Action Summary & Weekly Setup with High ROI Potential - newser.com
What earnings revisions data tells us about Lucid Diagnostics Inc.Fed Meeting & Daily Market Momentum Tracking - newser.com
Understanding Lucid Diagnostics Inc.’s price movement2025 Key Highlights & High Accuracy Buy Signal Tips - newser.com
Is Lucid Diagnostics Inc. trending in predictive chart modelsWeekly Stock Summary & Smart Swing Trading Techniques - newser.com
What MACD and RSI say about Lucid Diagnostics Inc.July 2025 Levels & Weekly High Return Opportunities - newser.com
Lucid Diagnostics Stock Sinks After-Hours On Equity Raise, But Retail Dives In Anyway - MSN
Using flow based indicators on Lucid Diagnostics Inc.Trade Volume Summary & High Win Rate Trade Alerts - newser.com
Lucid Diagnostics Inc Stock Analysis and ForecastTechnical Breakout Signals & Double Digit Wealth Tips - earlytimes.in
Can Lucid Diagnostics Inc. recover in the next quarterWeekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
How sentiment analysis helps forecast Lucid Diagnostics Inc.Portfolio Update Report & Expert Approved Momentum Trade Ideas - newser.com
Earnings visualization tools for Lucid Diagnostics Inc.Weekly Market Summary & Fast Entry High Yield Tips - newser.com
PAVmed subsidiary Veris Health launches cancer care platform at OSU center - Investing.com Canada
Lucid Diagnostics (NASDAQ:LUCD) Price Target Raised to $8.00 - MarketBeat
Ascendiant Capital Maintains Lucid Diagnostics (LUCD) Buy Recommendation - Nasdaq
Ascendiant Capital Raises Price Target for Lucid Diagnostics (LU - GuruFocus
Will Lucid Diagnostics Inc. stock benefit from automationMarket Weekly Review & Verified Chart Pattern Trade Signals - newser.com
Can Lucid Diagnostics Inc. stock beat analyst upgradesWeekly Trend Recap & Comprehensive Market Scan Insights - newser.com
Lucid Diagnostics (NASDAQ:LUCD) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
What sentiment indicators say about Lucid Diagnostics Inc. stockJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - newser.com
What recovery options are there for Lucid Diagnostics Inc.Weekly Market Report & Reliable Price Breakout Signals - newser.com
Reversal indicators forming on Lucid Diagnostics Inc. stockInsider Selling & Consistent Profit Alerts - newser.com
Will a bounce in Lucid Diagnostics Inc. offer an exit2025 Top Gainers & Trade Opportunity Analysis - newser.com
Identifying reversal signals in Lucid Diagnostics Inc.Earnings Trend Report & Daily Technical Forecast Reports - newser.com
Tick level data insight on Lucid Diagnostics Inc. volatilityTrade Performance Summary & AI Driven Stock Reports - newser.com
Brokerages Set Lucid Diagnostics Inc. (NASDAQ:LUCD) PT at $3.65 - Defense World
Altoona firefighters receive cancer screenings - WJAC
Lucid Diagnostics Inc. (NASDAQ:LUCD) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Lucid Diagnostics Inc Azioni (LUCD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Lucid Diagnostics Inc Azioni (LUCD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Matheis Dennis | Director |
May 20 '25 |
Buy |
1.29 |
187,098 |
242,292 |
187,098 |
| Matheis Dennis | Director |
May 21 '25 |
Buy |
1.32 |
129,684 |
171,520 |
316,782 |
| Matheis Dennis | Director |
May 22 '25 |
Buy |
1.32 |
33,218 |
43,795 |
350,000 |
1.23%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):